-
-
-
-
-
-
-
Traws Pharma names John Leaman to board, removes interim CEO and CFO titles
-
-
-
-
-
-
-
Traws Pharma (TRAW) Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
-
-
-
-
-
-
-
Traws Pharma, Inc. (TRAW) Misses Q3 EPS by 856c
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

